| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
BEGalapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies.
Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis.
The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Henry Gosebruch
Chief Executive Officer & Executive Director
Annelies Missotten
Executive Officer
Aaron L. Cox
Chief Financial Officer
Ellen Van Der Aar
Head of Development
Employees
452
Country
BE
Sector
Healthcare
Website
lakefrontbio.com
Loading congressional disclosures…
BE30d Avg
--
60d Avg
--
90d Avg
--
